Methylation and phosphorylation: A tangled relationship?

Clinical Chemistry

Volumn 53, Issue 6, 2007, Pages 999-1000

  McCaddon, Andrew ^a   Hudson, Peter R ^b  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b WREXHAM MAELOR HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; FOLIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; HOMOCYSTEINE; MICROTUBULE ASSOCIATED PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2A; S ADENOSYLHOMOCYSTEINE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN DISEASE; CEREBROSPINAL FLUID LEVEL; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DISEASE COURSE; EDITORIAL; ENZYME ACTIVATION; HUMAN; HYPERHOMOCYSTEINEMIA; INFLAMMATION; MAJOR CLINICAL STUDY; METHYLATION; MICROTUBULE; MOUSE; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PICK PRESENILE DEMENTIA; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AGE FACTORS; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CYSTEINE; FOLIC ACID; HUMANS; METHYLATION; PHOSPHORYLATION; S-ADENOSYLHOMOCYSTEINE; TAU PROTEINS; TAUOPATHIES;

EID: 34249873033     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.086579     Document Type: Editorial

References (17)

1. Williams DR. Tauopathles: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Intern Med J 2006;36:652-60.
2. Bunker JM, Wilson L, Jordan MA, Feinstein SC. Modulation of microtubule dynamics by tau in living cells: implications for development and neurodegeneration. Mol Biol Cell 2004;15:2720-8.
3. Feijoo C, Campbell DG, Jakes R, Goedert M, Cuenda A. Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38delta at Thr50 promotes microtubule assembly. J Cell Sci 2005;118:397-408.
4. Okawa Y, Ishiguro K, Fujita SC. Stress-induced hyperphosphorylation of tau in the mouse brain. FEBS Lett 2003;535:183-8.
5. Stoothoff WH, Johnson GV. Tau phosphorylation: physiological and pathological consequences. Biochim Biophys Acta 2005;1739:280-97.
6. Arnaud L, Robakis NK, Figueiredo-Pereire ME. It may take inflammation, phosphorylation and ubiquitination to 'tangle' in Alzheimer's disease. Neurodegener Dis 2006;3:313-9.
7. Wang JZ, Grundke-Iqbal I, Iqbal K. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 2007;25:59-68.
8. Vafal SB, Stock JB. Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer's Disease. FEBS Lett 2002;518:1-4.
9. McCaddon A. Homocysteine and cognition: a historical perspective. J Alzheimers Dis 2006;9:361-80.
10. Zou CG, Banerjee R. Homocysteine and redox signaling. Antioxid Redox Signal 2005;7:547-59.
11. Obeid R, Kasoha M, Knapp J-P, Kostopoulos P, Becker G, Fassbender K, et al. Folate and methylation status in relation to phosphorylated tau protein(181P) end [beta]amyloid(1-42) in cerebrospinal fluid. Clin Chem 2007;1129-36.
12. Heneka MT, O'Banion MK. Inflammatory processes in Alzheimer's disease. J Neuroimmunol 2007;184:69-91.
13. Balastik M, Lim J, Pastorino L, Lu KP. Pin1 in Alzheimer's disease: Multiple substrates, one regulatory mechanism? Biochim Biophys Acta 2007;1772:422-9.
14. Widner B, Enzinger C, Lalch A, Wirleitner B, Fuchs D. Hyperhomocystaine-mia, pteridines and oxidative stress. Curr Drug Metab 2002;3:225-32.
15. McCaddon A, Regland B, Hudson P, Davlee G. Functional vitamin B(12) deficiency and Alzheimer disease. Neurology 2002;58:1395-9.
16. Chan A, Shea TB. Dietary and genetically-induced oxidative stress alter tau phosphorylation: influence of folate and apolipoprotein E deficiency. J Alzheimers Dis 2006;9:399-405.
17. Frick B, Gruber B, Schroecksnadel K, Leblhuber F, Fuchs D. Homocysteine but not neopterin declines in demented patients on B vitamins. J Neural Transm 2006;113:1815-9.